BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6296567)

  • 1. Receptor-related interactions of opiates with PGE-induced adenylate cyclase in brain.
    Barchfeld CC; Maassen ZF; Medzihradsky F
    Life Sci; 1982 Oct 18-25; 31(16-17):1661-5. PubMed ID: 6296567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine 3':5'-cyclic monophosphate (cAMP) is not the mediator of kappa opiate effect on human placental lactogen release.
    Petit A; Gallo-Payet N; Lehoux JG; Bellabarba D; Bélisle S
    Life Sci; 1991; 49(6):465-72. PubMed ID: 1650874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
    Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes.
    Cooper DM; Londos C; Gill DL; Rodbell M
    J Neurochem; 1982 Apr; 38(4):1164-7. PubMed ID: 6278084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of opiates and prostaglandins E with regard to cyclic AMP in striatal tissue of rats in vitro.
    Havemann U; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Mar; 302(1):103-6. PubMed ID: 206843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum.
    Gentleman S; Parenti M; Neff NH; Pert CB
    Cell Mol Neurobiol; 1983 Mar; 3(1):17-26. PubMed ID: 6309392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord.
    Attali B; Saya D; Vogel Z
    J Neurochem; 1989 Feb; 52(2):360-9. PubMed ID: 2536070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate tolerance and dependence is associated with a decreased activity of GTPase in rat striatal membranes.
    Parenti M; Gazzotti G; Tirone F; Groppetti A
    Life Sci; 1983; 33 Suppl 1():345-8. PubMed ID: 6141494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of opiates on human colonic adenylate cyclase activity.
    Rachmilewitz D; Karmeli F; Chorev M; Selinger Z
    Eur J Pharmacol; 1983 Sep; 93(3-4):169-73. PubMed ID: 6580173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the desensitization by morphine of the opiate-dependent adenylate cyclase system in the rat striatum on the activity of the inhibitory regulatory G protein.
    Tirone F; Viganó A; Groppetti A; Parenti M
    Biochem Pharmacol; 1988 Mar; 37(6):1039-44. PubMed ID: 2833270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor-sensitive adenylate cyclase is inhibited by activation of mu-opioid receptors in rat striatal neurons.
    Van Vliet BJ; Ruuls SR; Drukarch B; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1991 Mar; 195(2):295-300. PubMed ID: 1651867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinities of opiate agonists and antagonists for the enkephalin receptors of rat brain.
    Wong DT; Horng JS
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):749-52. PubMed ID: 193169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of morphine of prostaglandin E2 (PGE2)-sensitive adenylate cyclase in corpus striatum of rats and its cellular localization by using kainic acid.
    Havemann U; Kuschinsky K
    Brain Res; 1978 Jul; 150(2):441-5. PubMed ID: 209852
    [No Abstract]   [Full Text] [Related]  

  • 19. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiates modulation of cAMP levels and PGE2 binding in mammalian sympathetic ganglia.
    Borasio PG; Biondi C; Capuzzo A; Ferretti ME
    Neurosci Lett; 1986 May; 66(1):7-12. PubMed ID: 2872633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.